De Rubertis Francesco has submitted a new 13F notice, detailing its investment holdings as of September 30, 2026. This filing is significant as it provides insights into the company’s investment strategies and positions in the market.

De Rubertis Francesco is categorized as an investment management firm. The company is based in Geneva, Switzerland, and operates under the Central Index Key (CIK) number 0001601521. Recent filings include a 13F notice on August 4, 2026, and another on April 21, 2026, showcasing its ongoing activities in the investment sector.

The latest filing, accession number 0001193125-26-442884, was made on November 2, 2026. It includes a report type of 13F notice, indicating that it is not an amendment and provides a snapshot of the firm’s investment positions as of the end of September.

This filing may affect various stakeholders in the investment management industry, particularly those monitoring De Rubertis Francesco’s activities. The firm is also associated with Medicxi Ventures Management (Jersey) Ltd, which is noted as another manager in the filing.

The filing does not say what happens next.

Filing Details

The filing is categorized under the 1934 Act and is identified by SEC file number 028-19836, with a film number of 261510325. This information is crucial for tracking and referencing the filing within the SEC's database.

Contact Information

Francesco De Rubertis, who is listed as the signatory for the filing, can be reached at the phone number +41 22 207 86 30. This contact detail may be useful for stakeholders seeking further clarification on the filing or the firm's investment strategies.

Address Information

The official mailing address for De Rubertis Francesco is C/O Medicxi, Cours de Rive 10, Geneva, CH-1204, Switzerland. This non-U.S. location indicates the firm's international presence and operational base.

Note: The filing does not provide specific details about the investment holdings or strategies employed by De Rubertis Francesco as of September 30, 2026.